BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10629434)

  • 1. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality.
    Hennig J; Toll C; Schonlau P; Rohrmann S; Netter P
    Neuropsychobiology; 2000; 41(1):38-47. PubMed ID: 10629434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine correlates of temperamental traits in humans.
    Gerra G; Zaimovic A; Timpano M; Zambelli U; Delsignore R; Brambilla F
    Psychoneuroendocrinology; 2000 Jul; 25(5):479-96. PubMed ID: 10818282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects.
    Ruegg RG; Gilmore J; Ekstrom RD; Corrigan M; Knight B; Tancer M; Leatherman ME; Carson SW; Golden RN
    Biol Psychiatry; 1997 Dec; 42(12):1123-9. PubMed ID: 9426882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychobiological differences between the aggression and psychoticism dimension.
    Netter P; Hennig J; Rohrmann S
    Pharmacopsychiatry; 1999 Jan; 32(1):5-12. PubMed ID: 10071177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V; McLoughlin D; Dinan TG
    J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes.
    Monteleone P; Brambilla F; Bortolotti F; Ferraro C; Maj M
    Psychol Med; 1998 Jul; 28(4):975-83. PubMed ID: 9723152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
    Monteleone P; La Rocca A; Fuschino A; Bortolotti F; Maj M
    Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulsiveness and the prolactin response to d-fenfluramine.
    Evans J; Platts H; Lightman S; Nutt D
    Psychopharmacology (Berl); 2000 Apr; 149(2):147-52. PubMed ID: 10805609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.
    Gerra G; Zaimovic A; Ferri M; Zambelli U; Timpano M; Neri E; Marzocchi GF; Delsignore R; Brambilla F
    Biol Psychiatry; 2000 Jan; 47(2):127-36. PubMed ID: 10664829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic responsiveness in human cocaine users.
    Ghitza UE; Rothman RB; Gorelick DA; Henningfield JE; Baumann MH
    Drug Alcohol Depend; 2007 Jan; 86(2-3):207-13. PubMed ID: 16930852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
    Prochazka H; Sjögren M; Agren H
    J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ; Murray RM; O'Keane V
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted fenfluramine-evoked prolactin secretion in hypertensive rats.
    Stocker SD; Muldoon MF; Sved AF
    Hypertension; 2003 Oct; 42(4):719-24. PubMed ID: 12885788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
    Park SB; Williamson DJ; Cowen PJ
    Psychol Med; 1996 Nov; 26(6):1191-6. PubMed ID: 8931165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
    Baumann MH; Ayestas MA; Rothman RB
    Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men.
    Coccaro EF; Berman ME; Kavoussi RJ; Hauger RL
    Biol Psychiatry; 1996 Aug; 40(3):157-64. PubMed ID: 8830948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder.
    Coccaro EF; Kavoussi RJ; Hauger RL
    Int Clin Psychopharmacol; 1995 Sep; 10(3):177-9. PubMed ID: 8675971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.